Search research articles
Contact Us
Filters
Showing results (161-170 of 300) with videos related to
Page
of 30
Sort By:
Nuclear Medicine and Biology
|
January 12, 2015
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution
Oskar Vilhelmsson-Timmermand, Elmer Santos, Daniel L J Thorek, et al.
Molecular Pharmaceutics
|
November 14, 2013
Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy
Sarah M Cheal, Barney Yoo, Sarah Boughdad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer
Seng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Radiology
|
April 9, 2013
Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
E Ronan Ryan, Constantinos T Sofocleous, Heiko Schöder, et al.
Radiology
|
September 11, 2010
Global trends in hybrid imaging
Hedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Radiology
|
January 31, 2014
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival
Hebert Alberto Vargas, Cecilia Wassberg, Josef J Fox, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 7, 2003
Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response
George Sgouros, Shannon Squeri, Ase M Ballangrud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2007
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
Seng C Ong, Heiko Schöder, Snehal G Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy
Michael J Morris, Timothy Akhurst, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
Sarah M Cheal, Edward K Fung, Mitesh Patel, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 300) with videos related to
Sort By:
Page
of 30
Nuclear Medicine and Biology
|
January 12, 2015
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution
Oskar Vilhelmsson-Timmermand, Elmer Santos, Daniel L J Thorek, et al.
Molecular Pharmaceutics
|
November 14, 2013
Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy
Sarah M Cheal, Barney Yoo, Sarah Boughdad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer
Seng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Radiology
|
April 9, 2013
Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
E Ronan Ryan, Constantinos T Sofocleous, Heiko Schöder, et al.
Radiology
|
September 11, 2010
Global trends in hybrid imaging
Hedvig Hricak, Byung Ihn Choi, Andrew M Scott, et al.
Radiology
|
January 31, 2014
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival
Hebert Alberto Vargas, Cecilia Wassberg, Josef J Fox, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 7, 2003
Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response
George Sgouros, Shannon Squeri, Ase M Ballangrud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2007
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
Seng C Ong, Heiko Schöder, Snehal G Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy
Michael J Morris, Timothy Akhurst, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
Sarah M Cheal, Edward K Fung, Mitesh Patel, et al.
Page
of 30